Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
00:01:42 07/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.0530 USD | -0.28% |
|
-7.18% | -5.19% |
| Market Cap | 22.27M 19.77M 18.5M 16.77M 31.68M 2.15B 31.9M 222M 86.44M 1.1B 83.61M 81.82M 3.52B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25M 22.19M 20.77M 18.83M 35.55M 2.41B 35.81M 249M 97.02M 1.23B 93.85M 91.84M 3.95B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -0.28% | ||
| 1 week | -7.18% | ||
| Current month | -7.18% | ||
| 1 month | -11.67% | ||
| 3 months | -22.97% | ||
| 6 months | +6.64% | ||
| Current year | -5.19% |
| 1 week | 0.05 |  | 0.05 |
| 1 month | 0.05 | | 0.06 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/10/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 18/9/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 11/9/26 | Exercice | Chief Executive Officer | -13,216 | 0.1400% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.28% | -7.18% | -37.54% | -36.22% | 22.34M | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.31B | |
| +2.76% | -1.60% | +22.80% | +78.53% | 56.95B | |
| +0.24% | -1.34% | +3.41% | +34.31% | 48.3B | |
| -3.76% | -2.25% | +329.09% | +698.20% | 44.51B | |
| -2.30% | -3.35% | +26.81% | +30.88% | 43.8B | |
| +0.31% | -0.68% | +5.30% | +108.64% | 41.12B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.07B | |
| +4.51% | +8.43% | +37.27% | +34.97% | 28.97B | |
| -1.96% | -2.88% | -8.97% | -13.92% | 24.53B | |
| Average | +0.36% | -1.42% | +43.67% | +108.22% | 39.36B | |
| Weighted average by Cap. | +0.77% | -0.94% | +56.70% | +132.97% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.51 0.46 0.88 59.49 0.88 6.16 2.39 30.35 2.32 2.27 97.56 | 0.34 0.3 0.28 0.25 0.48 32.4 0.48 3.35 1.3 16.53 1.26 1.23 53.14 |
| Net income | -4.76M -4.23M -3.96M -3.59M -6.77M -459M -6.82M -47.51M -18.48M -234M -17.88M -17.49M -753M | -5.43M -4.82M -4.51M -4.09M -7.72M -524M -7.78M -54.19M -21.07M -267M -20.39M -19.95M -859M |
| Net Debt | 2.88M 2.55M 2.39M 2.17M 4.09M 277M 4.12M 28.71M 11.17M 141M 10.8M 10.57M 455M | 2.73M 2.42M 2.27M 2.05M 3.88M 263M 3.91M 27.21M 10.58M 134M 10.24M 10.02M 431M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/10/26 | US$0.0530 | -0.28% | 33,645 |
| 05/10/26 | US$0.0532 | -2.30% | 10,732 |
| 02/10/26 | US$0.0544 | 0.00% | 15,072 |
| 01/10/26 | US$0.0544 | -4.73% | 425,782 |
| 30/09/26 | US$0.0571 | 0.00% | 5,300 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
